Context Therapeutics Inc.
CNTX
$0.775
$0.0020.26%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 94.43M | 84.80M | 101.54M | 10.09M | 14.45M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.47M | 1.27M | 1.16M | 949.50K | 1.60M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 97.90M | 86.07M | 102.70M | 11.04M | 16.05M |
|
|||||
Total Current Assets | 97.90M | 86.07M | 102.70M | 11.04M | 16.05M |
Net Property, Plant & Equipment | 230.80K | 259.00K | 10.40K | 13.00K | 15.50K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 98.13M | 86.33M | 102.71M | 11.05M | 16.06M |
|
|||||
Total Accounts Payable | 1.45M | 1.03M | 611.50K | 2.05M | 2.38M |
Total Accrued Expenses | 2.33M | 1.11M | 981.80K | 549.40K | 1.80M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 107.30K | 104.20K | -- | -- | -- |
Total Finance Division Other Current Liabilities | 49.80K | 89.80K | 11.00K | 13.70K | 8.50K |
Total Other Current Liabilities | 49.80K | 89.80K | 11.00K | 13.70K | 8.50K |
Total Current Liabilities | 2.75M | 2.33M | 1.60M | 2.61M | 4.19M |
|
|||||
Total Current Liabilities | 2.75M | 2.33M | 1.60M | 2.61M | 4.19M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 112.10K | 140.20K | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.86M | 2.47M | 1.60M | 2.61M | 4.19M |
|
|||||
Common Stock & APIC | 190.05M | 175.29M | 175.08M | 80.17M | 79.93M |
Retained Earnings | -94.78M | -91.44M | -73.98M | -71.72M | -68.05M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 95.27M | 83.86M | 101.10M | 8.44M | 11.87M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 95.27M | 83.86M | 101.10M | 8.44M | 11.87M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 95.27M | 83.86M | 101.10M | 8.44M | 11.87M |
|